Sociodemographic characteristics and clinical features of patients with adult polycystic kidney disease undergoing hemodialysis

被引:0
|
作者
Alves, Everton Fernando [1 ]
Tsuneto, Luiza Tamie [2 ]
Borelli, Sueli Donizete [3 ]
Cadide, Renata Campos [1 ]
de Freitas, Rosane Almeida [1 ]
Franca Gravena, Angela Andreia [3 ]
Pelloso, Sandra Marisa [2 ]
de Barros Carvalho, Maria Dalva [2 ]
机构
[1] Univ Estadual Maringa, Programa Posgrad Ciencias Saude, Maringa, Parana, Brazil
[2] Univ Estadual Maringa, Programa Mestrado Ciencias Saude, Maringa, Parana, Brazil
[3] Univ Estadual Maringa, Programa Posgrad Ciencias Saude, Maringa, Parana, Brazil
关键词
POLYCYSTIC KIDNEY; AUTOSOMAL DOMINANT/epidemiology; POLYCYSTIC KIDNEY DISEASES; KIDNEY FAILURE; CHRONIC; END-STAGE RENAL DISEASE; HEMODIALYSIS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: To analyze the socio-demographic and clinical characteristics of patients with adult polycystic kidney disease admitted to hemodialysis services in Northwestern Parana state, Brazil. Methods: This was an observational, descriptive and retrospective longitudinal study. Medical records of patients with polycystic kidneys who initiated hemodialysis between 1995 and 2012, in four centers that treat patients of the coverage area of the 15th Regional Health Region of Parana state where analyzed. Results: We found that 10.3% of hemodialysis patients had polycystic kidney disease as a leading cause of stage 5 of chronic kidney disease. The mean age of patients was 54.9 +/- 9.4 years (ranging between 27 and 74 years), with equal gender distribution and Caucasian predominance (72.9%). The average age of dialysis initiation was 50 +/- 10.2 years. The most common comorbidity was systemic hypertension (66.7%). Liver cyst was the main extra-renal manifestation (10.4%). Twenty-five percent of the patients required renal transplantation, and (22.9%) undergone nephrectomy. The most widely used classes of antihypertensive drugs were beta-blockers (41.7%) and drugs that act on the renin-angiotensin system (31.3%), while 56.3% of patients were treated with recombinant human erythropoietin. Conclusions: This is a pioneering epidemiological study in Northwestern Parana state. We found in this population a sociodemographic and clinical profile of adult polycystic kidney disease similar to that of North America and Europe, probably because the ethnic constitution of the sample was predominantly of Euro-descendants.
引用
收藏
页码:156 / 162
页数:7
相关论文
共 50 条
  • [41] Clinical pattern of adult polycystic kidney disease in a northeastern region of Italy
    Corradi, V.
    Gastaldon, F.
    Virzi, G. M.
    de Cal, M.
    Soni, S.
    Chionh, C.
    Cruz, D. N.
    Clementi, M.
    Ronco, C.
    CLINICAL NEPHROLOGY, 2009, 72 (04) : 259 - 267
  • [42] Clinical characteristics and risk factors for kidney failure in patients with autosomal dominant polycystic kidney disease: A retrospective study
    Park, Hanil
    Paek, Jin Hyuk
    Kim, Yaerim
    Park, Woo Yeong
    Han, Seungyeup
    Jin, Kyubok
    MEDICINE, 2022, 101 (47) : E31838
  • [43] LAPAROSCOPIC NEPHRECTOMY IN HEMODIALYSIS PATIENTS WITH POLYCYSTIC KIDNEY DISEASE AS A STANDARD FOR INCLUDING IN THE KIDNEY WAITING LIST
    Reznik, Oleg
    Ananiev, Alexey
    Nevirovich, Evgeny
    Daineko, Vasiliy
    Skvortsov, Andrey
    Kutenkov, Alexey
    Kuzmin, Denis
    TRANSPLANT INTERNATIONAL, 2017, 30 : 387 - 387
  • [44] Cinacalcet may suppress kidney enlargement in hemodialysis patients with autosomal dominant polycystic kidney disease
    Shinya Nakatani
    Kozo Nishide
    Senji Okuno
    Eiji Ishimura
    Daijiro Kabata
    Fumiyuki Morioka
    Yuri Machiba
    Hideki Uedono
    Akihiro Tsuda
    Shigeichi Shoji
    Masaaki Inaba
    Katsuhito Mori
    Tomoyuki Yamakawa
    Masanori Emoto
    Scientific Reports, 11
  • [45] Mineral and bone disorders and survival in hemodialysis patients with and without polycystic kidney disease
    Lukowsky, Lilia R.
    Molnar, Miklos Z.
    Zaritsky, Joshua J.
    Sim, John J.
    Mucsi, Istvan
    Kovesdy, Csaba P.
    Kalantar-Zadeh, Kamyar
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (07) : 2899 - 2907
  • [46] Cinacalcet may suppress kidney enlargement in hemodialysis patients with autosomal dominant polycystic kidney disease
    Nakatani, Shinya
    Nishide, Kozo
    Okuno, Senji
    Ishimura, Eiji
    Kabata, Daijiro
    Morioka, Fumiyuki
    Machiba, Yuri
    Uedono, Hideki
    Tsuda, Akihiro
    Shoji, Shigeichi
    Inaba, Masaaki
    Mori, Katsuhito
    Yamakawa, Tomoyuki
    Emoto, Masanori
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [47] Iron indices and survival in maintenance hemodialysis patients with and without polycystic kidney disease
    Hatamizadeh, Parta
    Ravel, Vanessa
    Lukowsky, Lilia R.
    Molnar, Miklos Z.
    Moradi, Hamid
    Harley, Kevin
    Pahl, Madeline
    Kovesdy, Csaba P.
    Kalantar-Zadeh, Kamyar
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (11) : 2889 - 2898
  • [48] Abdominal aortic aneurysms in hemodialysis patients with autosomal dominant polycystic kidney disease
    Kato, A
    Takita, T
    Furuhashi, M
    Maruyama, Y
    Hishida, A
    NEPHRON, 2001, 88 (02): : 185 - 186
  • [49] CLINICAL-FEATURES OF PRURITUS AMONG PATIENTS UNDERGOING MAINTENANCE HEMODIALYSIS
    GILCHREST, BA
    STERN, RS
    STEINMAN, TI
    BROWN, RS
    ARNDT, KA
    ANDERSON, WW
    ARCHIVES OF DERMATOLOGY, 1982, 118 (03) : 154 - 156
  • [50] Clinical characteristics of polycystic kidney disease with end-stage renal disease
    Konoshita, T
    Okamoto, K
    Koni, I
    Mabuchi, H
    CLINICAL NEPHROLOGY, 1998, 50 (02) : 113 - 117